Frost Radar™: Digital Pathology, 2024
Published on: 16-Oct-2024 | SKU: HC_2024_1065

Need more details?
$4,950.00
DownloadLink
Need more details?

This Frost Radar™ benchmarks companies offering digital pathology solutions for hospitals and laboratories and discusses opportunities in clinical, pharma, CRO, and research applications.

Digital pathology solutions cover all aspects of workflow including sample collection and preparation, image acquisition and integrated image storage, and analysis and management services. It highlights the top 13 companies that generated revenue from these solutions between 2021 and 2024.

The global market was valued at about $3.8 billion in 2023. Frost & Sullivan projects annual growth of between 12% to 15% over the next few years, and expects the user base to increase 10% to 12% annually but average per-user prices to continue to decline amid intense competition. Solution providers will need more value-added features to increase their per-user income.

Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.

Strategic Imperative

Growth Environment

Frost Radar™: Digital Pathology, 2024

Frost Radar™ Competitive Environment

Frost Radar™ Competitive Environment (continued)

Frost Radar™ Competitive Environment (continued)

3DHISTECH

3DHISTECH (continued)

3DHISTECH (continued)

Evident

Evident (continued)

Evident (continued)

Hamamatsu Photonics

Hamamatsu Photonics (continued)

Hamamatsu Photonics (continued)

Huron Digital Pathology

Huron Digital Pathology (continued)

Huron Digital Pathology (continued)

Indica Labs

Indica Labs (continued)

Indica Labs (continued)

Leica Biosystems

Leica Biosystems (continued)

Leica Biosystems (continued)

OptraSCAN

OptraSCAN (continued)

OptraSCAN (continued)

Paige AI

Paige AI (continued)

Paige AI (continued)

PathAI

PathAI (continued)

PathAI (continued)

Philips Healthcare

Philips Healthcare (continued)

Philips Healthcare (continued)

Proscia

Proscia (continued)

Proscia (continued)

Roche Diagnostics

Roche Diagnostics (continued)

Roche Diagnostics (continued)

Visiopharm

Visiopharm (continued)

Visiopharm (continued)

Best Practices

Growth Opportunities

Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform

Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform (continued)

Significance of Being on the Frost Radar™

Frost Radar™ Empowers the CEO’s Growth Team

Frost Radar™ Empowers Investors

Frost Radar™ Empowers Customers

Frost Radar™ Empowers the Board of Directors

Next Steps

Legal Disclaimer

Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform

Growth Index

Growth Index (GI) is a measure of a company’s growth performance and track record, along with its ability to develop and execute a fully aligned growth strategy and vision; a robust growth pipeline system; and effective market, competitor, and end-user focused sales and marketing strategies.

  • Market Share (previous 3 years)
    This is a comparison of a company’s market share relative to its competitors in a given market space for the previous 3 years.
  • Revenue Growth (previous 3 years)
    This is a look at a company’s revenue growth rate for the previous 3 years in the market/industry/category that forms the context for the given Frost Radar™.
  • Growth Pipeline
    This is an evaluation of the strength and leverage of a company’s growth pipeline system to continuously capture, analyze, and prioritize its universe of growth opportunities.
  • Vision and Strategy
    This is an assessment of how well a company’s growth strategy is aligned with its vision. Are the investments that a company is making in new products and markets consistent with the stated vision?
  • Sales and Marketing
    This is a measure of the effectiveness of a company’s sales and marketing efforts in helping it drive demand and achieve its growth objectives.

Innovation Index

Innovation Index (II) is a measure of a company’s ability to develop products/ services/ solutions (with a clear understanding of disruptive Mega Trends) that are globally applicable, are able to evolve and expand to serve multiple markets and are aligned to customers’ changing needs.

  • INNOVATION SCALABILITY
    This determines whether an organization’s innovations are globally scalable and applicable in both developing and mature markets, and also in adjacent and non-adjacent industry verticals.
  • RESEARCH AND DEVELOPMENT
    This is a measure of the efficacy of a company’s R&D strategy, as determined by the size of its R&D investment and how it feeds the innovation pipeline.
  • PRODUCT PORTFOLIO
    This is a measure of a company’s product portfolio, focusing on the relative contribution of new products to its annual revenue.
  • MEGATRENDS LEVERAGE
    This is an assessment of a company’s proactive leverage of evolving, long-term opportunities and new business models, as the foundation of its innovation pipeline.
  • CUSTOMER ALIGNMENT
    This evaluates the applicability of a company’s products/services/solutions to current and potential customers, as well as how its innovation strategy is influenced by evolving customer needs.

Significance of Being on the Frost Radar™

Companies plotted on the Frost RadarTM are the leaders in the industry for growth, innovation, or both. They are instrumental in advancing the industry into the future.

  • GROWTH POTENTIAL
    Your organization has significant future growth potential, which makes it a Company to Action.
  • BEST PRACTICES
    Your organization is well positioned to shape Growth Pipeline™ best practices in your industry.
  • COMPETITIVE INTENSITY
    Your organization is one of the key drivers of competitive intensity in the growth environment.
  • CUSTOMER VALUE
    Your organization has demonstrated the ability to significantly enhance its customer value proposition.
  • PARTNER POTENTIAL
    Your organization is top of mind for customers, investors, value chain partners, and future talent as a significant value provider.

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This Frost Radar benchmarks companies offering digital pathology solutions for hospitals and laboratories and discusses opportunities in clinical, pharma, CRO, and research applications. Digital pathology solutions cover all aspects of workflow including sample collection and preparation, image acquisition and integrated image storage, and analysis and management services. It highlights the top 13 companies that generated revenue from these solutions between 2021 and 2024. The global market was valued at about $3.8 billion in 2023. Frost & Sullivan projects annual growth of between 12% to 15% over the next few years, and expects the user base to increase 10% to 12% annually but average per-user prices to continue to decline amid intense competition. Solution providers will need more value-added features to increase their per-user income. Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar . The publication presents competitive profiles of each company on the Frost Radar considering their strengths and the opportunities that best fit those strengths.
More Information
Deliverable Type Frost Radar
Author Chandni Hussain
Industries Healthcare
No Index No
Is Prebook No
Keyword 1 digital pathology market
Keyword 2 diagnostic tech trends
Keyword 3 pathology innovation
Podcast No
WIP Number PFPZ-01-00-00-00

Frost Radar™: Digital Pathology, 2024

HealthcareFrost Radar™: Digital Pathology, 2024

A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines

RELEASE DATE
16-Oct-2024
REGION
Global
Deliverable Type
Frost Radar
Research Code: PFPZ-01-00-00-00
SKU: HC_2024_1065
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC_2024_1065